封面
市场调查报告书
商品编码
1618181

眼科缝合线市场机会、成长驱动因素、产业趋势分析及 2024 年至 2032 年预测

Ophthalmic Sutures Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 to 2032

出版日期: | 出版商: Global Market Insights Inc. | 英文 130 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023 年,全球眼科缝合线市场价值为 9.063 亿美元,预计 2024-2032 年复合年增长率为 6.2%。这种增长主要是由于眼部疾病的盛行率不断上升,特别是在老年人口中,以及白内障、青光眼和糖尿病视网膜病变等疾病发生率的上升。因此,眼科手术的需求不断增加,进一步推动市场扩张。市场分为两大类:天然缝合线和合成缝合线。 2023 年,合成材料领域成为领先者,收入达 6.205 亿美元。

合成缝合线是在严格的条件下生产的,可确保一致性和可靠性,这使得它们对于精确度至关重要的复杂眼科手术至关重要。聚丙烯、尼龙和聚乙醇酸等材料具有优异的拉伸强度、弹性和生物相容性,对于维持伤口完整性和促进敏感眼组织的癒合至关重要。这些功能的组合促进了市场对合成选项不断增长的需求。从涂层类型来看,眼科缝线可分为涂层和无涂层两类。

无涂层缝线预计将实现可观的收入,预计到2032 年将达到约11 亿美元。是眼科手术中的关键因素,在眼科手术中,安全结是必要的保持组织接近并防止滑动。此外,无涂层缝线不含其他物质,可最大限度地降低发炎反应的风险,这在处理脆弱的眼组织时尤其重要。 2023年北美眼科缝合线市场收入为3.535亿美元,预计未来几年将大幅成长。北美地区,尤其是人口老化地区,与年龄相关的眼部疾病数量不断增加,正在推动眼科手术的需求。人口趋势和强大的医疗基础设施相结合,使北美成为眼科缝合线市场的关键参与者,为扩张和创新提供了充足的机会。

市场范围
开始年份 2023年
预测年份 2024-2032
起始值 9.063 亿美元
预测值 16 亿美元
复合年增长率 6.2%

目录

第 1 章:方法与范围

第 2 章:执行摘要

第 3 章:产业洞察

  • 产业生态系统分析
  • 产业影响力
    • 成长动力
      • 眼部疾病盛行率不断上升
      • 技术进步
      • 糖尿病盛行率上升导致眼科疾病
      • 有利的政府倡议
      • 对微创手术的需求和偏好激增
    • 产业陷阱与挑战
      • 与眼科手术相关的术后併发症
      • 缺乏熟练的眼科医生
  • 成长潜力分析
  • 技术景观
  • 未来市场趋势
  • 监管环境
  • 报销场景
  • 按类型定价分析
  • 差距分析
  • 波特的分析
  • PESTEL分析

第 4 章:竞争格局

  • 介绍
  • 公司矩阵分析
  • 主要市场参与者的竞争分析
  • 公司市占率分析
  • 竞争定位矩阵
  • 战略仪表板

第 5 章:市场估计与预测:按类型,2021 - 2032

  • 主要趋势
  • 自然的
  • 合成的

第 6 章:市场估计与预测:按材料划分,2021 - 2032 年

  • 主要趋势
  • 职业高尔夫球协会
  • 尼龙
  • 丝绸
  • 聚丙烯
  • 其他材料

第 7 章:市场估计与预测:按涂料分类,2021 - 2032 年

  • 主要趋势
  • 涂层
  • 无涂层

第 8 章:市场估计与预测:按材料结构,2021 - 2032

  • 主要趋势
  • 单丝
  • 复丝/编织

第 9 章:市场估计与预测:按吸收率划分,2021 - 2032 年

  • 主要趋势
  • 可吸收
  • 不可吸收

第 10 章:市场估计与预测:按应用分类,2021 - 2032

  • 主要趋势
  • 白内障手术
  • 角膜移植手术
  • 青光眼手术
  • 玻璃体切除术
  • 眼部整形手术
  • 其他应用

第 11 章:市场估计与预测:按最终用途,2021 - 2032 年

  • 主要趋势
  • 医院
  • 门诊手术中心
  • 其他最终用户

第 12 章:市场估计与预测:按地区划分,2021 - 2032 年

  • 主要趋势
  • 北美洲
    • 我们
    • 加拿大
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 南非
    • 阿联酋

第 13 章:公司简介

  • Alcon
  • Assut Medical
  • Aurolab
  • Accutome
  • B Braun Melsungen AG
  • Corzamedical
  • DemeTECH Corporation.
  • Ethicon (J&J)
  • FCI Ophthalmics
  • Geuder AG
  • Mani
  • Medtronic
  • Teleflex Incorporated
  • Unilene
简介目录
Product Code: 3358

The Global Ophthalmic Sutures Market was worth USD 906.3 million in 2023 and is projected to grow at a 6.2% CAGR throughout 2024-2032. This growth is largely fueled by the increasing prevalence of eye disorders, particularly among the aging population, as well as the rising incidence of conditions such as cataracts, glaucoma, and diabetic retinopathy. Consequently, the demand for ophthalmic surgeries is on the rise, further propelling market expansion. The market is divided into two main categories: natural and synthetic sutures. In 2023, the synthetic segment emerged as the leader, generating revenue of USD 620.5 million.

Synthetic sutures are produced under stringent conditions that ensure consistency and reliability, making them essential for intricate ophthalmic procedures where precision is critical. Materials such as polypropylene, nylon, and polyglycolic acid exhibit excellent tensile strength, elasticity, and biocompatibility vital for maintaining wound integrity and promoting healing in sensitive eye tissues. This combination of features contributes to the growing demand for synthetic options in the market. Regarding coating types, ophthalmic sutures can be classified into coated and uncoated categories.

The uncoated segment is anticipated to achieve significant revenue, projected to reach around USD 1.1 billion by 2032. Uncoated sutures generally possess a higher friction coefficient than their coated counterparts, which enhances knot security-a crucial factor in ophthalmic procedures where secure knots are necessary to maintain tissue approximation and prevent slippage. Furthermore, the absence of additional substances in uncoated sutures minimizes the risk of inflammatory reactions, which is especially important when dealing with delicate eye tissues. The North American ophthalmic sutures market accounted for USD 353.5 million in revenue in 2023 and is expected to experience considerable growth in the coming years. The increasing number of age-related eye disorders in North America, particularly in regions with aging populations, is driving demand for ophthalmic procedures.Additionally, advanced healthcare facilities that can handle complex surgeries play a significant role in the market's growth. The combination of demographic trends and robust healthcare infrastructure positions North America as a key player in the ophthalmic sutures market, providing ample opportunities for expansion and innovation.

Market Scope
Start Year2023
Forecast Year2024-2032
Start Value$906.3 Million
Forecast Value$1.6 Billion
CAGR6.2%

Table of Contents

Chapter 1 Methodology & Scope

  • 1.1 Market scope & definition
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates & calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Growing prevalence of eye diseases
      • 3.2.1.2 Technological advancements
      • 3.2.1.3 Rising prevalence of diabetes leading to ophthalmic disorders
      • 3.2.1.4 Favorable government initiatives
      • 3.2.1.5 Surging demand and preference for minimally invasive surgeries
    • 3.2.2 Industry pitfalls & challenges
      • 3.2.2.1 Postoperative complications associated with ophthalmic procedures
      • 3.2.2.2 Lack of skilled ophthalmologist
  • 3.3 Growth potential analysis
  • 3.4 Technology landscape
  • 3.5 Future market trends
  • 3.6 Regulatory landscape
  • 3.7 Reimbursement scenario
  • 3.8 Pricing analysis, by type
  • 3.9 Gap analysis
  • 3.10 Porter's analysis
  • 3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major market players
  • 4.4 Company market share analysis
  • 4.5 Competitive positioning matrix
  • 4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Natural
  • 5.3 Synthetic

Chapter 6 Market Estimates and Forecast, By Material, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 PGA
  • 6.3 Nylon
  • 6.4 Silk
  • 6.5 Polypropylene
  • 6.6 Other materials

Chapter 7 Market Estimates and Forecast, By Coating, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Coated
  • 7.3 Uncoated

Chapter 8 Market Estimates and Forecast, By Material Structure, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Monofilament
  • 8.3 Multifilament/braided

Chapter 9 Market Estimates and Forecast, By Absorption, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 Absorbable
  • 9.3 Non-absorbable

Chapter 10 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 10.1 Key trends
  • 10.2 Cataract surgery
  • 10.3 Corneal transplantation surgery
  • 10.4 Glaucoma surgery
  • 10.5 Vitrectomy
  • 10.6 Oculoplastic surgery
  • 10.7 Other applications

Chapter 11 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

  • 11.1 Key trends
  • 11.2 Hospitals
  • 11.3 Ambulatory surgical centers
  • 11.4 Other end users

Chapter 12 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 12.1 Key trends
  • 12.2 North America
    • 12.2.1 U.S.
    • 12.2.2 Canada
  • 12.3 Europe
    • 12.3.1 Germany
    • 12.3.2 UK
    • 12.3.3 France
    • 12.3.4 Italy
    • 12.3.5 Spain
    • 12.3.6 Netherlands
  • 12.4 Asia Pacific
    • 12.4.1 China
    • 12.4.2 Japan
    • 12.4.3 India
    • 12.4.4 Australia
    • 12.4.5 South Korea
  • 12.5 Latin America
    • 12.5.1 Brazil
    • 12.5.2 Mexico
    • 12.5.3 Argentina
  • 12.6 Middle East and Africa
    • 12.6.1 Saudi Arabia
    • 12.6.2 South Africa
    • 12.6.3 UAE

Chapter 13 Company Profiles

  • 13.1 Alcon
  • 13.2 Assut Medical
  • 13.3 Aurolab
  • 13.4 Accutome
  • 13.5 B Braun Melsungen AG
  • 13.6 Corzamedical
  • 13.7 DemeTECH Corporation.
  • 13.8 Ethicon (J&J)
  • 13.9 FCI Ophthalmics
  • 13.10 Geuder AG
  • 13.11 Mani
  • 13.12 Medtronic
  • 13.13 Teleflex Incorporated
  • 13.14 Unilene